 Connection
Vishal Rana to Dacarbazine
This is a "connection" page, showing publications Vishal Rana has written about Dacarbazine.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.079 |
|
|
|
-
Lee HJ, Ramchandren R, Friedman J, Melear J, Flinn IW, Burke JM, Linhares Y, Gonzales P, Peterson M, Raval M, Chintapatla R, Feldman TA, Yimer H, Islas-Ohlmayer M, Patel A, Metheny L, Dean A, Rana V, Gandhi MD, Renshaw J, Ho L, Fanale MA, Guo W, Yasenchak CA. Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for advanced-stage classical Hodgkin lymphoma. Blood. 2025 01 16; 145(3):290-299.
Score: 0.054
-
Sonbol MB, Rana V, Kenderian SS, Finnes H, Witzig TE. Therapeutic options for patients with lymphoma and liver dysfunction or failure during mechlorethamine shortage. Leuk Lymphoma. 2014 Aug; 55(8):1815-21.
Score: 0.025
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|